Active Pharmaceutical Ingredients (APIs) play a pivotal role in pharmacodynamics, the study of how drugs exert their therapeutic effects on the body. These biologically active components are the core elements responsible for the physiological changes resulting from drug administration. By interacting with specific molecular targets, such as receptors or enzymes, APIs modulate cellular and biochemical processes, ultimately influencing the desired therapeutic outcomes.
Understanding the pharmacodynamics of APIs is crucial for determining the drug's efficacy, potency, and safety profile. It involves unraveling the intricate mechanisms by which these substances engage with biological systems, leading to a comprehensive comprehension of their therapeutic impact. Pharmacodynamic studies not only aid in optimizing drug dosages but also contribute to the development of safer and more effective pharmaceutical interventions. As researchers delve deeper into the dynamic interplay between APIs and the human body, advancements in pharmacology continue to pave the way for innovative and targeted therapeutic solutions.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary